Pseudopterosins might one day be integral components in drugs used to treat inflammatory conditions such as psoriasis, sunburn and arthritis.Pharmacologists at Scripps Institute and the University of California Santa Barbara hold the patent on pseudopterosin drugs and have licensed a biotech company, Nereus Pharmaceuticals, to investigate their capabilities.